Market Tracker

08/24 7:56am ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

3.78
Delayed Data
As of Aug 23
 +0.13 / +3.56%
Today’s Change
1.63
Today|||52-Week Range
11.50
+87.13%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.65
Today’s open3.64
Day’s range3.55 - 3.95
Volume107,226
Average volume (3 months)91,834
Market cap$41.1M
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+74.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...+0.01+6.55%
OGENOragenics Inc-0.06-6.37%
FCSCFibrocell Science In...-0.02-1.55%
CNATConatus Pharmaceutic...0.000.00%
Data as of 08/23/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts